| Guatemala | | |
Incidents of all cancers (age-standardized rate, per 100,000 population) | 123.1 (2020) [137/185countries] | | | Incidents of cancer at bladder (age-standardized rate, per 100,000 population) | 0.8 (2020) [181/184countries] | | | Incidents of cancer at brain, central nervous system (age-standardized rate, per 100,000 population) | 1.5 (2020) [134/181countries] | | | Incidents of cancer at breast (age-standardized rate, per 100,000 population) | 29.8 (2020) [149/185countries] | | | Incidents of cancer at cervix uteri (age-standardized rate, per 100,000 population) | 20.3 (2020) [54/185countries] | | | Incidents of cancer at colorectum (age-standardized rate, per 100,000 population) | 4.3 (2020) [141/185countries] | | | Incidents of cancer at corpus uteri (age-standardized rate, per 100,000 population) | 2.5 (2020) [154/183countries] | | | Incidents of cancer at gallbladder (age-standardized rate, per 100,000 population) | 0.4 (2020) [125/177countries] | | | Incidents of cancer at kidney (age-standardized rate, per 100,000 population) | 1.9 (2020) [119/182countries] | | | Incidents of cancer at larynx (age-standardized rate, per 100,000 population) | 0.6 (2020) [167/184countries] | | | Incidents of cancer at leukaemia (age-standardized rate, per 100,000 population) | 5.3 (2020) [90/185countries] | | | Incidents of cancer at lip and oral cavity (age-standardized rate, per 100,000 population) | 1.3 (2020) [141/183countries] | | | Incidents of cancer at liver (age-standardized rate, per 100,000 population) | 15.6 (2020) [12/185countries] | | | Incidents of cancer at lung (age-standardized rate, per 100,000 population) | 3.4 (2020) [152/185countries] | | | Incidents of cancer at skin (age-standardized rate, per 100,000 population) | 3.6 (2020) [93/183countries] | | | Incidents of cancer at multiple myeloma (age-standardized rate, per 100,000 population) | 0.4 (2020) [159/178countries] | | | Incidents of cancer at nasopharynx (age-standardized rate, per 100,000 population) | 0.1 (2020) [161/172countries] | | | Incidents of cancer at lymphoma (age-standardized rate, per 100,000 population) | 3.3 (2020) [156/184countries] | | | Incidents of cancer at oesophagus (age-standardized rate, per 100,000 population) | 1.0 (2020) [150/183countries] | | | Incidents of cancer at oropharynx (age-standardized rate, per 100,000 population) | 0.3 (2020) [120/173countries] | | | Incidents of cancer at ovary (age-standardized rate, per 100,000 population) | 3.4 (2020) [163/185countries] | | | Incidents of cancer at pancreas (age-standardized rate, per 100,000 population) | 2.3 (2020) [129/184countries] | | | Incidents of cancer at prostate (age-standardized rate, per 100,000 population) | 49.0 (2020) [67/185countries] | | | Incidents of cancer at stomach (age-standardized rate, per 100,000 population) | 12.2 (2020) [32/184countries] | | | Incidents of cancer at testis (age-standardized rate, per 100,000 population) | 2.8 (2020) [58/174countries] | | | Incidents of cancer at thyroid (age-standardized rate, per 100,000 population) | 3.7 (2020) [99/184countries] | | |
|
| Guatemala | | |
Suicide, age-standardized (per 100 000 population) | 6.23 (2019) [124/183countries] | | | Suicide - male, age-standardized (per 100 000 population) | 10.31 (2019) [118/183countries] | | | Suicide - female, age-standardized (per 100 000 population) | 2.53 (2019) [126/183countries] | | | Suicide - 15-24 years (per 100,000 population) | 11.32 (2019) [37/183countries] | | | Suicide - 15-24 years, male (per 100,000 population) | 16.00 (2019) [36/183countries] | | | Suicide - 15-24 years, female (per 100,000 population) | 6.48 (2019) [31/183countries] | | | Suicide - 25-34 years (per 100,000 population) | 8.66 (2019) [73/183countries] | | | Suicide - 25-34 years, male (per 100,000 population) | 14.62 (2019) [63/183countries] | | | Suicide - 25-34 years, female (per 100,000 population) | 2.80 (2019) [102/183countries] | | | Suicide - 35-44 years (per 100,000 population) | 6.97 (2019) [122/183countries] | | | Suicide - 35-44 years, male (per 100,000 population) | 12.36 (2019) [110/183countries] | | | Suicide - 35-44 years, female (per 100,000 population) | 2.13 (2019) [143/183countries] | | | Suicide - 45-54 years (per 100,000 population) | 6.55 (2019) [142/183countries] | | | Suicide - 45-54 years, male (per 100,000 population) | 12.07 (2019) [128/183countries] | | | Suicide - 45-54 years, female (per 100,000 population) | 2.05 (2019) [148/183countries] | | | Suicide - 55-64 years (per 100,000 population) | 7.17 (2019) [138/183countries] | | | Suicide - 55-64 years, male (per 100,000 population) | 13.21 (2019) [131/183countries] | | | Suicide - 55-64 years, female (per 100,000 population) | 2.34 (2019) [143/183countries] | | | Suicide - 65-74 years (per 100,000 population) | 8.08 (2019) [136/183countries] | | | Suicide - 65-74 years, male (per 100,000 population) | 14.69 (2019) [127/183countries] | | | Suicide - 65-74 years, female (per 100,000 population) | 2.71 (2019) [142/183countries] | | | Suicide - 75-84 years (per 100,000 population) | 7.32 (2019) [151/183countries] | | | Suicide - 75-84 years, male (per 100,000 population) | 12.87 (2019) [148/183countries] | | | Suicide - 75-84 years, female (per 100,000 population) | 2.82 (2019) [153/183countries] | | | Suicide - 85 years and over (per 100,000 population) | 9.60 (2019) [164/183countries] | | |
|
|